The CAPTURA Project

The UK Government has established the Fleming Fund to respond to the global threat of antimicrobial resistance (AMR). The Fleming Fund Regional Grants Grants includes a “call for data”, which aims to expand the volume of historical and current data available on AMR and antimicrobial use (AMU) across regions in Africa and Asia.

The CAPTURA consortium has been awarded two out of four Regional grants to work with 12 countries in South and South East Asia to collect and analyse retrospective data on AMR and AMU in the human health sector in these countries.
CAPTURA aims to increase the volume of data available to improve spatiotemporal mapping of AMR and antimicrobial use (AMU).

This will be done by working with local governments to identify and subsequently assess the quality of available data on AMR and AMU. Relevant data will be collated and analysed to provide meta-data and give regional and inter-regional context. The project will also help identify gaps in data and areas for quality improvement that can be addressed in future initiatives to strengthen surveillance capacity. The information resource generated by the project will improve awareness, advocacy, policy, and interventions needed to combat AMR and antimicrobial misuse.

The CAPTURA Consortium

The CAPTURA consortium is led by the International Vaccine Institute (IVI), which will be in charge of the overall management of the grant as well as coordinating in-country work including organizing stakeholder meetings and in-country and regional trainings and workshops. The IVI will also support at-site data collection including in-country quality monitoring and compilation of datasets, grading and analysis. The CAPTURA consortium also includes as partners, The Brigham & Women’s Hospital (WHONET), The Public Health Surveillance Group (PHSG), and Oxford University’s Big Data Institute (BDI).

The WHONET microbiology database software is already actively used in most CAPTURA countries, capturing and standardizing data from diverse laboratory information systems into a common platform, facilitating integrated management, analysis, and interpretation of microbiological findings. John Stelling and the rest of the WHONET development team at Brigham & Women’s Hospital will be supporting data collection and collation from sites that use WHONET and support the in-country capacity building.
The Public Health Surveillance Group has significant experience in supporting local governments across Asia and Africa in conducting surveillance assessments and working with ministries to enhance surveillance and health systems will. Bill MacWright and his team from PHSG will work support in-country activities and provide subject matter expertise in the development of protocols, training modules and monitoring.
Prof. David Aanensen and team from the Big Data Institute, University of Oxford have developed global methods for mobile data capture ( and epidemiological data linkage ( to enable the analyses and visualization of very large datasets. Their expertise will guide the collection and analysis of datasets (including genomic data), interpretation, visualization, and delivery tools.